Product Description

🔹 Product Overview
Lupride Depot 3.75 mg Injection is a prescription hormonal therapy medicine used to treat hormone-dependent conditions in men, women, and children.
Contains Leuprolide Acetate 3.75 mg, a gonadotropin-releasing hormone (GnRH) agonist that helps regulate hormone production in the body.
Commonly prescribed for prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.

🔹 Key Uses
Treatment of advanced prostate cancer
Management of endometriosis
Treatment of uterine fibroids
Management of central precocious puberty (early puberty)
Used in certain fertility and reproductive hormone treatment protocols under specialist supervision.

🔹 Composition
Active ingredient: Leuprolide Acetate 3.75 mg
Drug class: GnRH Agonist
Long-acting depot injection formulation.

🔹 How It Works
Initially stimulates hormone production and then suppresses the release of sex hormones.
Reduces testosterone levels in men and estrogen levels in women.
Helps slow the growth of hormone-sensitive tissues and tumors.

🔹 Key Benefits
Effective hormone suppression therapy
Helps manage symptoms associated with endometriosis and uterine fibroids
Supports treatment of hormone-dependent prostate cancer
Long-acting depot formulation offers convenient dosing

🔹 Dosage and Administration
Administered by a qualified healthcare professional.
Given as a depot injection at intervals determined by the treating physician.
Dosage schedule depends on the medical condition being treated.
Regular monitoring may be required during therapy.

🔹 Possible Side Effects
Hot flashes
Increased sweating
Fatigue
Headache
Mood changes
Reduced libido
Injection site reactions
Bone density reduction with long-term use.

🔹 Precautions
Use only under specialist medical supervision.
Inform your doctor about osteoporosis, liver disease, or other ongoing medical conditions.
Regular monitoring of hormone levels may be recommended.
Not recommended during pregnancy.
Follow all medical instructions regarding treatment duration and follow-up.